Loading clinical trials...
Loading clinical trials...
Evaluation of Prognostic Factors for Tubo-ovarian Cancer in France: Surgical Thresholds, Geographical Distance, Age and Therapeutic Sequence
Evaluation of the following prognostic factors in France, based on national quotation data: volume per center, patient age, geographic distance from a clinical center, delay for chemotherapy,Upfront surgery.
Age
18 - No limit years
Sex
FEMALE
Healthy Volunteers
No
Uhmontpellier
Montpellier, France
Start Date
January 1, 2012
Primary Completion Date
December 30, 2021
Completion Date
December 30, 2021
Last Updated
January 24, 2022
22,500
ACTUAL participants
Lead Sponsor
University Hospital, Montpellier
NCT04550494
NCT05039801
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions